Will The New Generic EpiPen Be Cheaper?
Category: Pharmaceutical
FDA: Eisai ‘s “Rembima” approved as a hepatocellular cancer drug
China’s drug regulator launches nationwide investigation into vaccine producers
23andMe Is Sharing Its 5 Million Clients’ Genetic Data with Drug Giant GlaxoSmithKline
EISAI AND BIOGEN ANNOUNCE POSITIVE TOPLINE RESULTS OF THE FINAL ANALYSIS FOR BAN2401 AT 18 MONTHS